Cookie Consent by FreePrivacyPolicy.com
Datalog Logo
Free data on 57M+ companies
Home > England & Wales Companies > PROSIDION LIMITED
Company Information for

PROSIDION LIMITED

1 MORE LONDON PLACE, LONDON, SE1 2AF,
Company Registration Number
04600121
Private Limited Company
Liquidation

Company Overview

About Prosidion Ltd
PROSIDION LIMITED was founded on 2002-11-25 and has its registered office in London. The organisation's status is listed as "Liquidation". Prosidion Limited is a Private Limited Company registered in with Companies House and the accounts submission requirement is categorised as FULL
  • Annual turnover is £6.5 million or more
  • The balance sheet total is £ 3.26 million or more
  • Employs 50 or more employees
  • May be publically listed
  • May be a member of a group of companies meeting any of the above criteria
Key Data
Company Name
PROSIDION LIMITED
 
Legal Registered Office
1 MORE LONDON PLACE
LONDON
SE1 2AF
Other companies in KT16
 
Telephone01865782600
 
Previous Names
OSI DIABETES LIMITED13/08/2003
Filing Information
Company Number 04600121
Company ID Number 04600121
Date formed 2002-11-25
Country 
Origin Country United Kingdom
Type Private Limited Company
CompanyStatus Liquidation
Lastest accounts 31/03/2018
Account next due 31/12/2019
Latest return 25/11/2015
Return next due 23/12/2016
Type of accounts FULL
Last Datalog update: 2019-05-04 14:17:47
Primary Source:Companies House
There are multiple companies registered at this address, the registered address may be the accountant's offices for PROSIDION LIMITED
There are multiple accountancy firms based at this address. The accountancy firm could be one of these:   ERNST & YOUNG (EMEIA) SERVICES LIMITED   EY GLOBAL SERVICES LIMITED
Is this data useful to you?
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.
Companies with same name PROSIDION LIMITED
The following companies were found which have the same name as PROSIDION LIMITED. These may be the same company in different jurisdictions
  Registered addressLast known statusFormation date
PROSIDION LIMITED Unknown
Prosidion Capital Group, LLC 6231 Pga Blvd., Suite 104-570 Palm Beach Gardens FL 33418 Active Company formed on the 2020-06-05

Company Officers of PROSIDION LIMITED

Current Directors
Officer Role Date Appointed
STEPHEN SHEA KNOWLES
Director 2012-05-11
COLLETTE TAYLOR
Director 2012-05-11
Previous Officers
Officer Role Date Appointed Date Resigned
WILLIAM EMMETT FITZSIMMONS
Director 2011-01-01 2012-05-10
NAOKI OKAMURA
Director 2011-01-01 2012-05-10
JOHN HARVEY
Director 2007-07-20 2011-01-02
PIERRE LEGAULT
Director 2009-08-25 2011-01-02
JONATHAN RACHMAN
Director 2010-01-01 2010-12-03
ANKER LUNDEMOSE
Director 2003-02-01 2010-09-01
COLIN GODDARD
Director 2002-11-25 2010-07-02
MICHAEL ATIEH
Director 2005-06-07 2009-03-18
JONATHAN BROOKS
Company Secretary 2008-10-01 2009-03-16
SIAN SAMANTHA BISHOP
Company Secretary 2003-10-01 2008-07-31
ROBERT VAN NOSTRANO
Director 2004-05-26 2007-07-20
GEOFFREY COOPER
Director 2003-10-01 2005-06-07
DARYL GRANNER
Director 2003-10-01 2005-06-07
MISHA PETKEVICH
Director 2004-08-05 2005-06-07
DAVID LASKOW-POOLEY
Company Secretary 2002-11-25 2003-10-01
KIM ARTHUR HUEG
Director 2003-03-31 2003-10-01
SWIFT INCORPORATIONS LIMITED
Nominated Secretary 2002-11-25 2002-11-25
INSTANT COMPANIES LIMITED
Nominated Director 2002-11-25 2002-11-25

Related Directorships

Officer Related Company Role Date Appointed Role StatusIncorporation dateCompany Status
STEPHEN SHEA KNOWLES OSI PHARMACEUTICALS (UK) LIMITED Director 2012-05-11 CURRENT 1983-03-25 Dissolved 2013-11-28
STEPHEN SHEA KNOWLES OXFORD REAL ESTATE OWNER LIMITED Director 2012-05-11 CURRENT 2009-03-17 Dissolved 2016-05-19
STEPHEN SHEA KNOWLES OXFORD REAL ESTATE OWNER NO.2 LIMITED Director 2012-05-11 CURRENT 2009-04-16 Dissolved 2016-05-19
COLLETTE TAYLOR OSI PHARMACEUTICALS (UK) LIMITED Director 2012-05-11 CURRENT 1983-03-25 Dissolved 2013-11-28
COLLETTE TAYLOR OXFORD REAL ESTATE OWNER LIMITED Director 2012-05-11 CURRENT 2009-03-17 Dissolved 2016-05-19
COLLETTE TAYLOR OXFORD REAL ESTATE OWNER NO.2 LIMITED Director 2012-05-11 CURRENT 2009-04-16 Dissolved 2016-05-19

More director information

Corporation Filing History
Companies House Filing History
This is a record of the public documents (corporate filing) lodged from Companies House where the company has filed annual returns and other statutory filing documents. Examples of documents filed include: change of registered office, accounts filing, director/officer appointments & resignations, changes in share capital, shareholder members lists etc.

DateDocument TypeDocument Description
2020-01-08LIQ13Voluntary liquidation. Notice of members return of final meeting
2019-04-15AD01REGISTERED OFFICE CHANGED ON 15/04/19 FROM 2000 Hillswood Drive Chertsey KT16 0RS
2019-04-13LIQ01Voluntary liquidation declaration of solvency
2019-04-13600Appointment of a voluntary liquidator
2019-04-13LRESSPResolutions passed:
  • Special resolution to wind up on 2019-03-21
2019-02-14AAFULL ACCOUNTS MADE UP TO 31/03/18
2018-12-11CS01CONFIRMATION STATEMENT MADE ON 25/11/18, WITH NO UPDATES
2017-12-29AAFULL ACCOUNTS MADE UP TO 31/03/17
2017-12-07CS01CONFIRMATION STATEMENT MADE ON 25/11/17, WITH NO UPDATES
2017-01-12LATEST SOC12/01/17 STATEMENT OF CAPITAL;GBP 1054.13
2017-01-12CS01CONFIRMATION STATEMENT MADE ON 25/11/16, WITH UPDATES
2016-11-15AAFULL ACCOUNTS MADE UP TO 31/03/16
2016-01-15LATEST SOC15/01/16 STATEMENT OF CAPITAL;GBP 1054.13
2016-01-15AR0125/11/15 ANNUAL RETURN FULL LIST
2015-12-03AAFULL ACCOUNTS MADE UP TO 31/03/15
2015-01-07AAFULL ACCOUNTS MADE UP TO 31/03/14
2014-12-01LATEST SOC01/12/14 STATEMENT OF CAPITAL;GBP 1054.13
2014-12-01AR0125/11/14 ANNUAL RETURN FULL LIST
2013-12-19LATEST SOC19/12/13 STATEMENT OF CAPITAL;GBP 1054.13
2013-12-19AR0125/11/13 ANNUAL RETURN FULL LIST
2013-08-15AAFULL ACCOUNTS MADE UP TO 31/03/13
2013-06-19SH20Statement by directors
2013-06-19SH19Statement of capital on 2013-06-19 GBP 1,054.1300
2013-06-19CAP-SSSolvency statement dated 18/06/13
2013-06-19RES13Resolutions passed:<ul><li>Share premium account cancelled 18/06/2013</ul>
2013-01-03AAFULL ACCOUNTS MADE UP TO 31/03/12
2012-12-24AR0125/11/12 ANNUAL RETURN FULL LIST
2012-09-19AD01REGISTERED OFFICE CHANGED ON 19/09/12 FROM Astellas Pharma Europe Limited Lovett House Lovett Road Staines Middlesex TW18 3AZ
2012-07-05AP01DIRECTOR APPOINTED MS COLLETTE TAYLOR
2012-07-04TM01APPOINTMENT TERMINATED, DIRECTOR NAOKI OKAMURA
2012-07-04AP01DIRECTOR APPOINTED MR STEPHEN SHEA KNOWLES
2012-07-04TM01APPOINTMENT TERMINATED, DIRECTOR WILLIAM FITZSIMMONS
2012-03-21AD01REGISTERED OFFICE CHANGED ON 21/03/12 FROM Windrush Court Watlington Road Oxford Oxfordshire OX4 6LT
2011-12-29AR0125/11/11 ANNUAL RETURN FULL LIST
2011-12-12AAFULL ACCOUNTS MADE UP TO 31/03/11
2011-03-16AA01CURREXT FROM 31/12/2010 TO 31/03/2011
2011-01-25AP01DIRECTOR APPOINTED WILLIAM EMMETT FITZSIMMONS
2011-01-24AP01DIRECTOR APPOINTED NAOKI OKAMURA
2011-01-24TM01APPOINTMENT TERMINATED, DIRECTOR PIERRE LEGAULT
2011-01-24TM01APPOINTMENT TERMINATED, DIRECTOR JOHN HARVEY
2011-01-11AR0125/11/10 FULL LIST
2010-12-17TM01APPOINTMENT TERMINATED, DIRECTOR JONATHAN RACHMAN
2010-12-10AAFULL ACCOUNTS MADE UP TO 31/12/09
2010-09-10TM01APPOINTMENT TERMINATED, DIRECTOR ANKER LUNDEMOSE
2010-07-16TM01APPOINTMENT TERMINATED, DIRECTOR COLIN GODDARD
2010-03-12AP01DIRECTOR APPOINTED DR JONATHAN RACHMAN
2009-12-24AR0125/11/09 FULL LIST
2009-09-08288aDIRECTOR APPOINTED PIERRE LEGAULT
2009-07-25AAFULL ACCOUNTS MADE UP TO 31/12/08
2009-04-06288bAPPOINTMENT TERMINATED DIRECTOR MICHAEL ATIEH
2009-04-06288bAPPOINTMENT TERMINATED SECRETARY JONATHAN BROOKS
2008-12-22363aRETURN MADE UP TO 25/11/08; NO CHANGE OF MEMBERS
2008-12-22288cDIRECTOR'S CHANGE OF PARTICULARS / ANKER LUNDEMOSE / 01/11/2008
2008-10-09288bAPPOINTMENT TERMINATED SECRETARY SIAN BISHOP
2008-10-09288aSECRETARY APPOINTED JONATHAN BROOKS
2008-10-08AAFULL ACCOUNTS MADE UP TO 31/12/07
2007-12-19363(288)DIRECTOR'S PARTICULARS CHANGED
2007-12-19363sRETURN MADE UP TO 25/11/07; NO CHANGE OF MEMBERS
2007-11-30AAFULL ACCOUNTS MADE UP TO 31/12/06
2007-09-11288aNEW DIRECTOR APPOINTED
2007-08-31288bDIRECTOR RESIGNED
2007-01-16363sRETURN MADE UP TO 25/11/06; FULL LIST OF MEMBERS
2006-08-29AAFULL ACCOUNTS MADE UP TO 31/12/05
2006-05-22288aNEW DIRECTOR APPOINTED
2006-05-12225ACC. REF. DATE EXTENDED FROM 30/09/05 TO 31/12/05
2006-04-20363sRETURN MADE UP TO 25/11/05; CHANGE OF MEMBERS
2006-04-20288aNEW DIRECTOR APPOINTED
2006-03-31288bDIRECTOR RESIGNED
2006-03-31288bDIRECTOR RESIGNED
2006-03-31288bDIRECTOR RESIGNED
2005-10-14AAFULL ACCOUNTS MADE UP TO 30/09/04
2005-07-20244DELIVERY EXT'D 3 MTH 30/09/04
2005-04-29363(288)DIRECTOR'S PARTICULARS CHANGED
2005-04-29363sRETURN MADE UP TO 25/11/04; FULL LIST OF MEMBERS
2005-04-15MEM/ARTSARTICLES OF ASSOCIATION
2005-04-15RES01ALTERATION TO MEMORANDUM AND ARTICLES
2005-02-07RES13ALLOTMENT OF SHARES 11/06/04
2005-02-07RES01ALTERATION TO MEMORANDUM AND ARTICLES
2004-10-30288aNEW DIRECTOR APPOINTED
2004-10-30288aNEW DIRECTOR APPOINTED
Industry Information
SIC/NAIC Codes
72 - Scientific research and development
721 - Research and experimental development on natural sciences and engineering
72110 - Research and experimental development on biotechnology




Licences & Regulatory approval
We could not find any licences issued to PROSIDION LIMITED or authorisation from an industry specific regulator to operate. These may not be required.
Share this page on Facebook
Risks
Legal Notices
Resolutions for Winding-up2019-03-29
Appointment of Liquidators2019-03-29
Notice of Intended Dividends2019-03-29
Fines / Sanctions
No fines or sanctions have been issued against PROSIDION LIMITED
Liabilities
Mortgages / Charges
Total # Mortgages/Charges 0
Mortgages/Charges outstanding 0
Mortgages Partially Satisifed 0
Mortgages Satisfied/Paid 0
Details of Mortgagee Charges
PROSIDION LIMITED does not have any mortgage charges so there is no mortgagee data available

  Average Max
MortgagesNumMortCharges0.338
MortgagesNumMortOutstanding0.178
MortgagesNumMortPartSatisfied0.001
MortgagesNumMortSatisfied0.168

This shows the max and average number of mortgages for companies with the same SIC code of 72110 - Research and experimental development on biotechnology

Intangible Assets
Patents

Intellectual Property Patents Registered by PROSIDION LIMITED

PROSIDION LIMITED has registered 4 patents

GB2498968 , GB2498976 , GB2497351 , GB2488360 ,

Domain Names
We could not find the registrant information for the domain

PROSIDION LIMITED owns 3 domain names.

osidiabetes.co.uk   prosidion.co.uk   osiprosidion.co.uk  

Trademarks
We have not found any records of PROSIDION LIMITED registering or being granted any trademarks
Income
Government Income
We have not found government income sources for PROSIDION LIMITED. This could be because the transaction value was below £ 500 with local government or below £ 25,000 for central government. We have found 8,000 supplier to government that are UK companies so approx 0.2% of companies listed on Datalog supply to government.

The top companies supplying to UK government with the same SIC code (72110 - Research and experimental development on biotechnology) as PROSIDION LIMITED are:

Outgoings
Business Rates/Property Tax
No properties were found where PROSIDION LIMITED is liable for the business rates / property tax. This could be for a number of reasons.
  • The council hasnt published the data
  • We havent found or been able to process the councils data
  • The company is part of a group of companies and another company in the group is liable for business rates
  • The registered office may be a residential address which does not have a commercial designation. If the business is run from home then it won't be a commercial property and hence won't be liable for business rates.
  • Serviced offices are increasingly popular and therefore a business may not be paying business rates directly - the building owner is and this is incorporated in the office rental charge.
Import/Export of Goods
Goods imported/exported by PROSIDION LIMITED
OriginDestinationDateImport CodeImported Goods classification description
2011-11-0129349990Nucleic acids and their salts, whether or not chemically defined; heterocyclic compounds (excl. those with oxygen or nitrogen hetero-atom"s" only, compounds containing in the structure an unfused thiazole ring or a benzothiazole or phenothiazine ring-system or further fused, aminorex "INN", brotizolam "INN", clotiazepam "INN", cloxazolam "INN", dextromoramide "INN", haloxazolam "INN", ketazolam "INN", mesocarb "INN", oxazolam "INN", pemoline "INN", phendimetrazine "INN", phenmetrazine "INN", suf
2011-11-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2011-10-0129420000Separate chemically defined organic compounds, n.e.s.
2011-10-0130021099
2011-10-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2011-09-0123099099
2011-09-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2011-07-0129310099
2011-07-0130021099
2011-07-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2011-06-0129420000Separate chemically defined organic compounds, n.e.s.
2011-06-0130021099
2011-06-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2011-05-0123099099
2011-05-0130021099
2011-05-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2011-04-0129339980Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl
2011-04-0129420000Separate chemically defined organic compounds, n.e.s.
2011-04-0130021010Antisera
2011-04-0130021099
2011-04-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2011-03-0129339980Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl
2011-03-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2011-02-0129
2011-02-0129339980Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl
2011-02-0129420000Separate chemically defined organic compounds, n.e.s.
2011-02-0130021010Antisera
2011-02-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2011-02-0184219900Parts of machinery and apparatus for filtering or purifying liquids or gases, n.e.s.
2011-01-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2011-01-0184715000Processing units for automatic data-processing machines, whether or not containing in the same housing one or two of the following types of unit: storage units, input units, output units (excl. those of heading 8471.41 or 8471.49 and excl. peripheral units)
2010-12-0129163900
2010-12-0129310099
2010-12-0129333999Heterocyclic compounds with nitrogen hetero-atom[s] only, containing an unfused pyridine ring, whether or not hydrogenated, in the structure (excl. pyridine, piperidine, alfentanil "INN", anileridine "INN", bezitramide "INN", bromazepam "INN", difenoxin "INN", diphenoxylate "INN", dipipanone "INN", fentanyl "INN", ketobemidone "INN", methylphenidate "INN", pentazocine "INN", pethidine "INN", pethidine "INN" intermediate A, phencyclidine "INN" "PCP", phenoperidine "INN", pipradol "INN", piritrami
2010-12-0129420000Separate chemically defined organic compounds, n.e.s.
2010-12-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2010-12-0184219900Parts of machinery and apparatus for filtering or purifying liquids or gases, n.e.s.
2010-12-0184719000Magnetic or optical readers, machines for transcribing data onto data media in coded form and machines for processing such data, n.e.s.
2010-12-0184799080Parts of machines and mechanical appliances having individual functions, n.e.s. (excl. of cast iron or cast steel)
2010-11-0129420000Separate chemically defined organic compounds, n.e.s.
2010-11-0130021099
2010-11-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2010-10-0129224985Amino-acids and their esters; salts thereof (excl. those containing > one kind of oxygen function, lysine and its esters, and salts thereof, and glutamic acid, anthranilic acid, tilidine "INN" and their salts and beta-alanine)
2010-10-0129420000Separate chemically defined organic compounds, n.e.s.
2010-10-0130021099
2010-10-0130029090Toxins and similar products, e.g. plasmodia (excl. vaccines and cultures of micro-organisms)
2010-10-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2010-09-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2010-08-0129
2010-08-0129310099
2010-08-0129333999Heterocyclic compounds with nitrogen hetero-atom[s] only, containing an unfused pyridine ring, whether or not hydrogenated, in the structure (excl. pyridine, piperidine, alfentanil "INN", anileridine "INN", bezitramide "INN", bromazepam "INN", difenoxin "INN", diphenoxylate "INN", dipipanone "INN", fentanyl "INN", ketobemidone "INN", methylphenidate "INN", pentazocine "INN", pethidine "INN", pethidine "INN" intermediate A, phencyclidine "INN" "PCP", phenoperidine "INN", pipradol "INN", piritrami
2010-08-0129339980Heterocyclic compounds with nitrogen hetero-atom[s] only (excl. those containing an unfused pyrazole, imidazole, pyridine or triazine ring, whether or not hydrogenated, a quinoline or isoquinoline ring-system, not further fused, whether or not hydrogenated, a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, lactams, alprazolam "INN", camazepam "INN", chlordiazepoxide "INN", clonazepam "INN", clorazepate, delorazepam "INN", diazepam "INN", estazolam "INN", ethyl
2010-08-0129349990Nucleic acids and their salts, whether or not chemically defined; heterocyclic compounds (excl. those with oxygen or nitrogen hetero-atom"s" only, compounds containing in the structure an unfused thiazole ring or a benzothiazole or phenothiazine ring-system or further fused, aminorex "INN", brotizolam "INN", clotiazepam "INN", cloxazolam "INN", dextromoramide "INN", haloxazolam "INN", ketazolam "INN", mesocarb "INN", oxazolam "INN", pemoline "INN", phendimetrazine "INN", phenmetrazine "INN", suf
2010-08-0129420000Separate chemically defined organic compounds, n.e.s.
2010-08-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2010-07-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2010-06-0129310010
2010-06-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2010-05-0128275900Bromides and bromide oxides (excl. of sodium, potassium and mercury)
2010-04-0129331990Heterocyclic compounds with nitrogen hetero-atom[s] only, containing an unfused pyrazole ring, whether or not hydrogenated, in the structure (excl. phenazone "antipyrin" and its derivatives and phenylbutazone "INN")
2010-04-0129420000Separate chemically defined organic compounds, n.e.s.
2010-04-0130049000Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic purposes, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale (excl. medicaments containing antibiotics, medicaments containing hormones or steroids used as hormones, but not containing antibiotics, medicaments containing alkaloids or derivatives thereof but not containing hormones or antibiotics and medicaments containing provitamins, vitamins
2010-04-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2010-04-0139264000Statuettes and other ornamental articles, of plastics
2010-03-0129310010
2010-03-0129420000Separate chemically defined organic compounds, n.e.s.
2010-03-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2010-02-0129333999Heterocyclic compounds with nitrogen hetero-atom[s] only, containing an unfused pyridine ring, whether or not hydrogenated, in the structure (excl. pyridine, piperidine, alfentanil "INN", anileridine "INN", bezitramide "INN", bromazepam "INN", difenoxin "INN", diphenoxylate "INN", dipipanone "INN", fentanyl "INN", ketobemidone "INN", methylphenidate "INN", pentazocine "INN", pethidine "INN", pethidine "INN" intermediate A, phencyclidine "INN" "PCP", phenoperidine "INN", pipradol "INN", piritrami
2010-02-0129371900Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues, used primarily as hormones (excl. somatropin, its derivatives and structural analogues, and insulin and its salts)
2010-02-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)
2010-01-0129
2010-01-0129420000Separate chemically defined organic compounds, n.e.s.
2010-01-0138220000Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products)

For goods imported into the United Kingdom, only imports originating from outside the EU are shown

Legal Notices/Action
Initiating party Event TypeResolutions for Winding-up
Defending partyPROSIDION LIMITEDEvent Date2019-03-21
On March 21, 2019 the following written resolutions were passed by the shareholders of the company, as a special resolution and an ordinary resolution respectively: "THAT the Company be wound up voluntarily." "THAT Patrick Brazzill and Samantha Keen of Ernst & Young LLP, 1 More London Place, London SE1 2AF, be and they are hereby appointed Joint Liquidators for the purposes of the winding up." Date on which the resolutions were passed: March 21, 2019 Office Holder Details: Patrick Joseph Brazzill and Samantha Jane Keen (IP numbers 8569 and 9250 ) of Ernst & Young LLP , 1 More London Place, London SE1 2AF . Date of Appointment: 21 March 2019 . Further information about this case is available from Ellie Emery at the offices of Ernst & Young LLP on 020 7197 7282. Stephen Shea Knowles , Director :
 
Initiating party Event TypeAppointment of Liquidators
Defending partyPROSIDION LIMITEDEvent Date2019-03-21
Patrick Joseph Brazzill and Samantha Jane Keen of Ernst & Young LLP , 1 More London Place, London SE1 2AF : Further information about this case is available from Ellie Emery at the offices of Ernst & Young LLP on 020 7197 7282.
 
Initiating party Event TypeNotice of Intended Dividends
Defending partyPROSIDION LIMITEDEvent Date2019-03-21
As Joint Liquidators of the Company, we hereby give notice that we intend to make a final distribution to its creditors. The last date for proving is 2 May 2019 and creditors of the company should by that date send their full names and addresses and particulars of their debts or claims to me, Patrick Joseph Brazzill of Ernst & Young LLP, 1 More London Place, London SE1 2AF. In accordance with Rule 14.38(1)(c) of the Insolvency (England and Wales) Rules 2016, we may thereafter make the proposed distribution without regard to the claim of any person in respect of a debt not yet proved. Office Holder Details: Patrick Joseph Brazzill and Samantha Jane Keen (IP numbers 8569 and 9250 ) of Ernst & Young LLP , 1 More London Place, London SE1 2AF . Date of Appointment: 21 March 2019 . Further information about this case is available from Ellie Emery at the offices of Ernst & Young LLP on 020 7197 7282. Dated 28 March 2019 Patrick Joseph Brazzill , Joint Liquidator
 
Government Grants / Awards
Technology Strategy Board Awards
The Technology Strategy Board has not awarded PROSIDION LIMITED any grants or awards. Grants from the TSB are an indicator that the company is investing in new technologies or IPR
European Union CORDIS Awards
The European Union has not awarded PROSIDION LIMITED any grants or awards.
Ownership
    • ONCOGENE SCIENCE INC : Ultimate parent company :
    Is this data useful to you?
    If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
    Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.
    Need more information?
    We offer bespoke investigations into companies. If you need more information about this company we can gather more information as directed by you. This may, for example, be a forensic investigation such as tracing hidden assets. The engagement is on a time and materials basis. We charge GBP £ 500 per day + VAT. Contact us with a description of what you're looking for and we will assess whether we can help.